shiga-like toxins neutralized tailored multivalent carbohydrate ligands
diseases caused shiga cholera toxins account loss millions lives year belong clinically significant subset bacterial ab toxins consisting enzymatically active subunit gains entry susceptible mammalian cells oligosaccharide recognition b homopentamer therapies might target obligatory oligosaccharide-toxin recognition event low intrinsic affinity carbohydrate-protein interactions hampers development low-molecular-weight inhibitors toxins circumvent low affinity binding simultaneously five cell-surface carbohydrates demonstrate use crystal structure b subunit escherichia coli o157:h7 shiga-like toxin slt-i complex analogue carbohydrate receptor design oligovalent water-soluble carbohydrate ligand named starfish subnanomolar inhibitory activity vitro inhibitory activity -million-fold higher univalent ligands far highest molar activity inhibitor yet reported shiga-like toxins ii crystallography starfish/shiga-like toxin complex explains activity two trisaccharide receptors tips five spacer arms simultaneously engage five b subunits two toxin molecules
